Rodman & Renshaw Reiterates Buy Rating With a $6.00 Price Target for DS Healthcare Group, Inc. POMPANO BEACH, Fla., March 02, 2016 (GLOBE NEWSWIRE) -- Senior Biotechnology Analyst, Raghuram Selvaraju, Ph.D., of Rodman & Renshaw, (a unit of H.C. Wainwright & Co.) has reiterated his buy...